Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-κB, activation protein-1, and c-Jun N-terminal kinase

Journal of Interferon and Cytokine Research

Volumn 20, Issue 8, 2000, Pages 725-735

  Manna, S K ^a   Haridas, V ^a   Aggarwal, B B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL X; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

APOPTOSIS; BASE SEQUENCE; BCL-X PROTEIN; DNA; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033900954     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900050116435     Document Type: Article

References (51)

1. Early events in TNF signaling: A story of associations and dissociations
2. Two tumor necrosis factor receptors: Structure and function
3. NF-kappa B: Ten years after
4. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors
5. NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress
6. The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme (ICE)
7. Molecular structure and organization of the human manganese superoxide dismutase gene
8. Differential regulation of manganese superoxide dismutase activity by alcohol and TNF in human hepatoma cells
9. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B
10. Activate NF-kappa B or die?
11. Tumor necrosis factor-α stimulates AP-1 through prolonged activation of the c-jun kinase
12. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells
13. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor-α
14. AP-1 function and regulation
15. The regulation of AP-1 activity by mitogen-activated protein kinases
16. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases
17. Overexpression of Mn-superoxide dismutase suppresses TNF-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1
18. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
19. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity
20. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells
21. Overexpression of γ-glutamylcysteine synthetase abolishes tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1
22. Bcl-x(L) and Bcl-2 inhibit TNF and Fas induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
23. Bcl-x(L) functions downstream of caspase-8 to inhibit Fas and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells
24. Bcl-2, Bcl-x(L) and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death
25. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-x(L)
26. Recent progress on the regulation of apoptosis by Bcl-2 family members
27. Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death
28. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by Bcl-x(L) but not Bcl-2
29. Bcl-x(L) regulates the membrane potential and volume homeostasis of mitochondria
30. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
31. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
32. Bcl-2 inhibition of neuronal death: Decreased generation of reactive oxygen species
33. Assay for redox sensitive kinases
34. Overexpression of Bcl-2 or Bcl-x(L) inhibits Ara-C-induced CPP32/YAMA protease activity and apoptosis of human acute myelogeneous leukemia HL-60 cells
35. Microtiter plate radioreceptor assay for tumor necrosis factor and its receptors in large numbers of samples
36. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
37. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, NF-κB activation, and c-Jun kinase activation
38. Yama/CPP32, a mammalian homolog of ced-3, is a crm-A inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
39. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells
40. Protein tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB
41. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases
42. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens
43. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis
44. Bcl-2 downregulates the activity of transcription factor NF-kappa B induced upon apoptosis
45. Pleiotropic effects of Bcl-2 on transcription factors in T cells: Potential role of NF-κB p50-p50 for the antiapoptotic function of Bcl-2
46. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type
47. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
48. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
49. Ordering the cell death pathway. Differential effects of BCL 2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells
50. Activation of c-jun kinase antagnoizes an anti-apoptotic action of Bcl-2
51. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: Induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells